Trial intelligence / Profile preview

Vasoactive drugs with mini fluid loading test for predicting intraoperative volume responsiveness

ChiCTR2400088352Phase 4Not yet recruiting

Sponsor
Subei People's Hospital
Start
Aug 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of norepinephrine and phenylephrine in hypotension (3 arms), sponsored by Subei People's Hospital. Primary endpoint: Cardiac index. Planned start Aug 2024; status: not yet recruiting.

02

Drugs

norepinephrinephenylephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2400088352.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2400088352.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call